AVENUE THERAPEUTICS, INC. (ATXI): auditor change — Avenue Therapeutics dismisses BDO, engages KPMG as new auditor

AVENUE THERAPEUTICS, INC.

BDO dismissed as independent auditor effective Jan 21, 2023; prior reports had going concern explanatory paragraph.
No disagreements or reportable events during fiscal years 2021 and 2020 and subsequent interim periods.
KPMG engaged as new independent auditor for fiscal year ending Dec 31, 2022, effective Jan 23, 2023.
No prior consultations with KPMG on accounting principles, disagreements, or reportable events.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

AVENUE THERAPEUTICS, INC. dismissed BDO USA, LLP as its auditor.

Action: dismissal
Auditor: BDO USA, LLP
Successor: KPMG LLP

Exact text from the filing

On January 21, 2023, the Audit Committee (the “Audit Committee”) of the Board of Directors of Avenue Therapeutics, Inc. (the “Company”) dismissed BDO USA, LLP (“BDO”) as the Company’s independent registered public accounting firm, effective immediately.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

AVENUE THERAPEUTICS, INC. engaged KPMG LLP as its auditor.

Action: engagement
Auditor: KPMG LLP

Exact text from the filing

Effective as of January 23, 2023, the Audit Committee engaged KPMG LLP (“KPMG”) as the Company’s independent registered public accounting firm for the fiscal year ended December 31, 2022.

View on SEC.gov

Browse all auditor changes →

AVENUE THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001104659-23-006536

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.